Acromegaly: Evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy

Clinical Endocrinology

Volumn 56, Issue 5, 2002, Pages 595-602

  Herrmann, B L ^a   Bruch, C ^a   Saller, B ^a   Bartel, T ^a   Ferdin, S ^a   Erbel, R ^a   Mann, K ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE HYPERTROPHY; HUMAN; IMAGING; MALE; MITRAL VALVE; MUSCLE MASS; PRIORITY JOURNAL; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036274767     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01528.x     Document Type: Article

References (52)

1. Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients
2. Body composition in acromegaly: The effect of treatment
3. Echocardiographic evaluation of the size and systolic and diastolic function of heart muscle in patients with acromegaly
4. Tei-index in patients with mild-to-moderate congestive heart failure
5. Blood pressure-independent cardiac hypertrophy in acromegalic patients
6. Are patients with acromegaly at high risk for dysrhythmias?
7. Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study
8. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly
9. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly
10. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery
11. Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy
12. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease
13. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
14. Growth hormone and the heart
15. Cardiac effects of GH
16. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes
17. Cell death in acromegalic cardiomyopathy
18. Systolic and diastolic cardiac function in acromegaly. An echocardiographic study
19. Criteria for cure of acromegaly: A consensus statement
20. Occurrence of ventricular late potentials in patients with active acromegaly
21. Arrhythmia profile in acromegaly
22. Bone metabolism and body composition in Japanese patients with active acromegaly
23. A prospective Doppler study before and after therapy in essential hypertension
24. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons
25. Effect of inhibitors of signal transduction on IGF-1-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes
26. Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients
27. Cardiovascular aspects in acromegaly: Effects of treatment
28. Effect of growth hormone on cardiac function
29. Early detection of anthracycline-induced cardiomyopathy by means of a new echocardiographic Doppler-index
30. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion
31. Acromegaly
32. Cardiac dysfunction in acromegaly: Evidence by pulsed wave tissue Doppler imaging
33. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
34. Effects of growth hormone on glucose metabolism
35. Cardiac hypertrophy and function in asymptomatic acromegaly
36. Early abnormalities in left ventricular diastolic function of sodium-sensitive hypertensive patients
37. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures
38. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone
39. Body composition and energy expenditure in acromegaly
40. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy
41. Acromegalic cardiomyopathy: Evaluation of the left ventricular diastolic function in the subclinical stage
42. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: From the Investigators of Consensus on Diastolic Dysfunction by Echocardiography
43. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: Comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy
44. Growth hormone: A newcomer in cardiovascular medicine
45. Growth hormone and the heart
46. Pathogenesis and treatment of endocrine hypertension
47. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function
48. The Tei index - A role in the diagnosis of heart failure?
49. Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis
50. Shortened Doppler-derived mitral A wave deceleration time: An important predictor of elevated left ventricular filling pressure
51. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle
52. + current in ventricular myocytes from acromegalic rats